USSTOCK.TODAY
Regular Market
Log in Sign up

Akebia Therapeutics Announces Q3 2026 Results and Vafseo Sales Update

The Motley Fool +1 · ·by G4L

AKBA
AKBA Akebia Therapeutics Inc
$0.40 -5.69%
View chart & analysis →
  1. 1Akebia Therapeutics, Inc. announced its third quarter 2026 results.
  2. 2Akebia recorded $14.8 million in Vafseo net product sales for the quarter.
  3. 3CEO John Butler stated that a decrease in customer inventory impacted product sales.

So what's the key point?

Akebia Therapeutics released its third quarter 2026 financial results. Product sales reached $14.8 million as customer inventory levels declined.

Source The Motley Fool +1 · View original ↗

Related 3-line summaries

United Therapeutics Posts Q2 Net Income of $333 Million Associated Press +1 · Aug 5Marcus & Millichap Records $1 Million in Third Quarter Profit Associated Press +3 · 2d agoKingstone Companies hits record profitability with $17.6 million in Q3 net income The Motley Fool +1 · 2d ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news